Ikena Oncology
Presence
Ikena Oncology is a company listed under the stock ticker IKNA (US).
Executives
View the org chart displaying its 19 main executives
Most searched biographies at Ikena Oncology
- Mark Manfredi, Director, President and Chief Executive Officer
- Owen Hughes, Chairman of the Board
- Richard Wooster, Director
Popular executive movements at Ikena Oncology
- Sergio Santillana, Chief Medical Officer, has left the company (posted on February 22 2024).
- Caroline Germa has joined the company as Chief Medical Officer (posted on February 22 2024).
Create your alert
to follow the executive moves at Ikena Oncology.
Biotechnology
Ikena Oncology has 2,274 competitors including Eurofins (Luxembourg), Lonza (Switzerland) and Adaptive Phage Therapeutics (United States (USA)).
Popular M&A news in Biotechnology
- Bruker has announced the acquisition of NanoString Technologies (posted on April 18 2024).
- Vertex Pharmaceuticals has announced the acquisition of Alpine Immune Sciences (posted on April 16 2024).
- Nurix Therapeutics has just announced a $175 Million fundraising (posted on April 13 2024).
Popular contacts in Biotechnology
News
Press releases by Ikena Oncology
- Ikena Oncology to Participate in the William Blair Biotech Focus Conference 2022 | Ikena Oncology
- Ikena Oncology Receives FDA Fast Track Designation for Novel TEAD Inhibitor IK-930 to Treat Unresectable NF2-Deficient Mesothelioma | Ikena Oncology
- Ikena Oncology to Participate in Spring 2022 Investor Conferences | Ikena Oncology
- Ikena Oncology Reports First Quarter 2022 Financial Results and Provides a Corporate Update | Ikena Oncology
- Ikena Oncology and Vall d’Hebron Institute of Oncology Announce Research & Development Collaboration | Ikena Oncology
- Ikena Oncology to Present at the American Society of Clinical Oncology (ASCO) 2022 Annual Meeting | Ikena Oncology
- Ikena Oncology to Present Preclinical Findings on IK-930, a Novel TEAD Inhibitor at the 2022 American Association for Cancer Research (AACR) Annual Meeting | Ikena Oncology
- Ikena Oncology Reports Fourth Quarter and Full Year 2021 Financial Results and Corporate Update | Ikena Oncology
- Ikena Appoints Richard Wooster, Ph.D., to its Board of Directors | Ikena Oncology
- Ikena Oncology to Participate in Cowen 42nd Annual Health Care Conference | Ikena Oncology
- View more press releases Close
Social media about Ikena Oncology
- Ikena Oncology on Wikipedia, Google News & Yahoo Finance
- Ikena Oncology on LinkedIn, Twitter & YouTube
Get in Touch
Contact by email its executives including Mark Manfredi 
Call Ikena Oncology at +1 -8...
